Centessa Pharmaceuticals PLC ADR
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -238 | -228 | ||
EBITDA | -79,773 | -87,995 | -51,598 | -46,455 |
EBIT | -80,011 | -87,315 | -51,835 | -46,681 |
Net Income | -79,241 | -66,163 | -54,891 | -50,343 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -72,224 | -55,817 | -58,546 | -22,578 |
Cash | 62,431 | 61,299 | 50,811 | 44,242 |
Basic Shares | 153,549 | 135,715 | 134,163 | 133,677 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $15,000 | $0 | $6,853 | $0 |
Gross Profit | 15,000 | -942 | 6,853 | -131 |
EBITDA | -207,692 | -221,881 | -165,425 | -209,546 |
EBIT | -222,823 | -166,235 | -209,677 | |
Net Income | -197,532 | -235,757 | -151,085 | -216,207 |
Net Change In Cash | 15,000 | 0 | 6,853 | 0 |
Free Cash Flow | -194,188 | -142,089 | -160,511 | -201,683 |
Cash | 61,299 | 383,221 | 128,030 | 393,644 |
Basic Shares | 135,715 | 114,473 | 96,178 | 93,400 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.52 |
2025-12-31 | -$0.48 |
2025-09-30 | -$0.41 |
2025-06-30 | -$0.38 |